Psychedelic Assisted Psychotherapy and the Push for Faster Approval
- Dr. Mariya, PsyD

- 1 day ago
- 4 min read
Psychedelic assisted psychotherapy is gaining attention as a promising approach to healing trauma and emotional wounds. This therapy combines the use of psychedelic medicines with guided psychological support to help people process deep emotional pain and build resilience. Over recent years, research has shown encouraging results, and efforts to speed up approval of these treatments have increased, including notable actions during the Trump administration.
In this article, I will share what I’ve learned about psychedelic assisted psychotherapy, the major medicines involved, and how recent policy changes have influenced their availability. I will also mention some helpful resources for those interested in exploring this path.

What Is Psychedelic Assisted Psychotherapy?
Psychedelic assisted psychotherapy is a treatment approach that uses psychedelic substances alongside professional therapy sessions. The goal is to help individuals access and work through difficult emotions, memories, and trauma that may be hard to reach through traditional talk therapy alone.
The therapy usually involves a few guided sessions where the patient takes a controlled dose of a psychedelic medicine under the supervision of a trained therapist. These sessions are supported by preparation beforehand and integration work afterward to help make sense of the experience and apply insights to daily life.
This approach is especially relevant for people who have experienced trauma or emotional neglect. It can help calm the nervous system, build self-trust, and create a sense of safety within oneself and in relationships.
Major Psychedelic Medicines in Therapy
Several psychedelic substances have been studied for their therapeutic potential. Here are some of the most researched:
Psilocybin
Psilocybin is the active compound found in certain mushrooms. Research shows it can reduce symptoms of depression, anxiety, and PTSD when combined with therapy. It works by temporarily altering brain activity, allowing new perspectives and emotional breakthroughs.
MDMA
MDMA, often known as ecstasy, is being studied for its ability to help people with PTSD. It promotes feelings of safety and connection, making it easier to process traumatic memories without becoming overwhelmed.
Ketamine
Ketamine is a dissociative anesthetic that has been used off-label for depression and trauma. It acts quickly to relieve symptoms and is often combined with therapy to support lasting change.
How the Trump Administration Influenced Psychedelic Medicine Approval
During the Trump administration, there was a notable push to speed up the approval process for some psychedelic medicines, especially MDMA and psilocybin. The Food and Drug Administration (FDA) granted "breakthrough therapy" status to these substances, which helps fast-track their development and review.
This status was based on promising clinical trial results showing significant benefits for people with treatment-resistant PTSD and depression. The goal was to make these therapies available sooner for those who need them.
While the administration’s overall stance on drug policy was complex, this move showed a willingness to consider new approaches to mental health treatment. It opened doors for more research funding and clinical trials.

Research Supporting Psychedelic Assisted Psychotherapy
Several studies have demonstrated the potential of psychedelic assisted psychotherapy:
A 2021 study published in Nature Medicine found that psilocybin therapy led to significant reductions in depression symptoms, with effects lasting up to a year.
MDMA-assisted therapy for PTSD showed a 67% remission rate in a Phase 3 clinical trial, according to research funded by the Multidisciplinary Association for Psychedelic Studies (MAPS).
Ketamine infusions combined with therapy have been shown to reduce suicidal thoughts rapidly in some patients.
These results suggest that psychedelics can be powerful tools when used carefully and with professional support.
Integrating Psychedelic Therapy Into Healing Trauma
For those who have experienced trauma or emotional neglect, psychedelic assisted psychotherapy offers a new way to heal. It can help calm the nervous system and create space for self-trust and connection.
Dr. Mariya, PsyD, offers trauma-informed somatic therapy that complements these approaches by focusing on the body’s role in healing. Combining somatic therapy with psychedelic experiences can deepen the healing process.
If you are curious about exploring this path, consider looking into reputable providers who offer guided psychedelic therapy sessions. For example, Mindful Pathways provides safe, professional psychedelic-assisted therapy with experienced clinicians.
Comparing Psychedelic Therapy Services
If you are exploring options, here are two services that stand out:
Mindful Pathways
Offers guided psychedelic therapy sessions with licensed therapists. They focus on trauma healing and nervous system regulation.
Healing Horizons
Provides integrative therapy combining somatic approaches with psychedelic-assisted sessions. They emphasize building resilience and safe connections.
Both services prioritize safety, professional support, and trauma-informed care. Choosing the right one depends on your personal needs and comfort.

Healing from trauma and emotional neglect is a journey that requires patience and support. Psychedelic assisted psychotherapy offers a new way to access deep healing and build resilience. With growing research and faster approval processes, these therapies are becoming more accessible.
If you feel drawn to this approach, take time to research and connect with trusted providers. Healing is possible, and new paths are opening to support you.
Disclaimer: This article is for informational purposes only and does not replace professional medical advice. Always consult a qualified healthcare provider before starting any new treatment.



Comments